Health Management Associates, Inc. (HMA) rated Buy with price target $13 by Auriga
Auriga rated Buy Health Management Associates, Inc. (NYSE: HMA) on 07/22/2011, when the stock price was $10.40. Since
then, Health Management Associates, Inc. has gained 4.42% as of 05/22/2013's recent price of $10.86. If you would have followed this Auriga's recommendation on HMA, you would have gained 4.42% of your investment in 670 days.
Health Management Associates, Inc.
operates general acute-care hospitals in non-urban communities. Services provided by its hospitals include general surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care and pediatric services. As of December 31, 2008, Health Management Associates, Inc.
operated 56 hospitals with a total of 8,019 licensed beds in Alabama, Arkansas, Florida, Georgia, Kentucky, Mississippi, Missouri, North Carolina, Oklahoma, Pennsylvania, South Carolina, Tennessee, Texas, Washington and West Virginia. On August 28, 2008, the Company completed the sale of Southwest Regional Medical Center, On June 1, 2008, Health Management Associates, Inc.
closed its Woman?s Center at Dallas Regional Medical Center (Center).On January 1, 2008. it closed its Gulf Coast Medical Center.
operates full-service institutional equity and fixed income trading desks with state-of-the-art communications technology and trading systems. Through our U.S. corprate parent, Auriga
Holdings, LLC we offer a variety of services including whole loan trading and asset management. Through our Spanish parent company, Auriga
Securities Sociedad de Valores, S.A., we offer the ability to trade European equity and fixed income products. We connect electronically to buy-side firms; route orders to multiple points of execution and subsequently route to our clearing firm, Pershing, for settlement.